Moderators of real-world effectiveness of smoking cessation aids: a population study

Addiction

Volumn 114, Issue 9, 2019, Pages 1627-1638

  Jackson, Sarah E ^a   Kotz, Daniel ^a,b   West, Robert ^a   Brown, Jamie ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

behavioural support; bupropion; cessation aids; e cigarettes; nicotine replacement therapy; real world effectiveness; smoking cessation; varenicline

Indexed keywords

AMFEBUTAMONE; NON PRESCRIPTION DRUG; VARENICLINE;

ADOLESCENT; ADULT; AGE; AGED; COUNSELING; CROSS-SECTIONAL STUDY; DRUG THERAPY; ELECTRONIC CIGARETTE; ENGLAND; FEMALE; HUMAN; HYPNOSIS; INTERNET; MALE; MIDDLE AGED; PROCEDURES; QUESTIONNAIRE; SEX FACTOR; SMOKING CESSATION; SOCIAL CLASS; TELEPHONE; TOBACCO DEPENDENCE; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BUPROPION; COUNSELING; CROSS-SECTIONAL STUDIES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; ENGLAND; FEMALE; HUMANS; HYPNOSIS; INTERNET; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; SEX FACTORS; SMOKING CESSATION; SMOKING CESSATION AGENTS; SOCIAL CLASS; SURVEYS AND QUESTIONNAIRES; TELEPHONE; TOBACCO USE CESSATION DEVICES; TOBACCO USE DISORDER; TREATMENT OUTCOME; VARENICLINE; YOUNG ADULT;

EID: 85068610389     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.14656     Document Type: Article

References (53)

1. Pirie K., Peto R., Reeves G. K., Green J., Beral V. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 2013; 381: 133–141.
2. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004; 328: 1519.
3. Brown J., Beard E., Kotz D., Michie S., West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014; 109: 1531–1540.
4. Kotz D., Brown J., West R. ‘Real-world’ effectiveness of smoking cessation treatments: a population study. Addiction 2014; 109: 491–499.
5. Kotz D., Brown J., West R. Prospective cohort study of the effectiveness of smoking cessation treatments used in the ‘real world’. In: Mayo Clinic Proceedings. Oxford, UK: Elsevier; 2014, pp. 1360–1367.
6. Chaiton M, Diemert LM, Bondy SJ, Cohen JE, Fung MD, Zhang BR, Ferrence R. Real-world effectiveness of pharmaceutical smoking cessation aids: time-varying effects. Nicotine Tob Res [internet] [accessed 13 October 2018]; Available at: https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/nty194/5107580
7. Benmarhnia T., Pierce J. P., Leas E., White M. M., Strong D. R., Noble M. L., et al. Can e-cigarettes and pharmaceutical aids increase smoking cessation and reduce cigarette consumption? Findings from a nationally representative cohort of American smokers. Am J Epidemiol 2018; 187: 2397–2404.
8. Taylor G. M., Taylor A. E., Thomas K. H., Jones T., Martin R. M., Munafò M. R., et al. The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical records. Int J Epidemiol 2017; 46: 1948–1957.
9. Smith P. H., Kasza K. A., Hyland A., Fong G. T., Borland R., Brady K., et al. Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey. Nicotine Tob Res 2015; 17: 463–472.
10. Yong H.-H., Hitchman S. C., Cummings K. M., Borland R., Gravely S. M. L., McNeill A., et al. Does the regulatory environment for E-cigarettes influence the effectiveness of E-cigarettes for smoking cessation? Longitudinal findings from the ITC Four Country Survey. Nicotine Tob Res 2017; 19: 1268–1276.
11. Cahill K., Stevens S., Perera R., Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013CD009329.
12. Anthenelli R. M., Benowitz N. L., West R., Aubin L. S., McRae T., Lawrence D., et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 2016; 387: 2507–2520.
13. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. physician advice for smoking cessation. Cochrane Database Syst Rev 2013; CD000165. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000165.pub4/abstract
14. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2017; CD001292. https://doi.org/10.1002/14651858.CD001292. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001292.pub3/abstract
15. Stead L. F., Carroll A. J., Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2017; CD001007. https://doi.org/10.1002/14651858. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001007.pub3/abstract
16. Whittaker R., McRobbie H., Bullen C., Rodgers A. G. Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev 2016CD006611.
17. Hartmann-Boyce J., Lancaster T., Stead L. F. Print-based self-help interventions for smoking cessation. Cochrane Database Syst Rev 2014; 6: CD001118.
18. West R., Raw M., McNeill A., Stead L., Aveyard P., Bitton J., et al. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction 2015; 110: 1388–1403.
19. Taylor G. M. J., Dalili M. N., Semwal M., Civljak M., Sheikh A., Car J. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev 2017CD007078.
20. McRobbie H., Bullen C., Hartmann-Boyce J., Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014; 12: CD010216.
21. O'Brien B., Knight-West O., Walker N., Parag V., Bullen C. E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial. Tob Induc Dis 2015; 13: 5.
22. West R., Evins A. E., Benowitz N. L., Russ C., McRae T., Lawrence D., et al. Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES. Addiction 2018; 113: 1507–1516.
23. Hiscock R., Bauld L., Amos A., Fidler J. A., Munafò M. Socioeconomic status and smoking: a review. Ann NY Acad Sci 2012; 1248: 107–123.
24. Hymowitz N., Cummings K. M., Hyland A., Lynn W. R., Pechacek T. F., Hartwell T. D. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control 1997; 6: S57–S62.
25. Hyland A., Li Q., Bauer J. E., Giovino G. A., Steger C., Cummings K. M. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res 2004; 6: S363–S369.
26. Hyland A., Borland R., Li Q., Yong H.-H., McNeill A., Fong G. T., et al. Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control 2006; 15: iii83–iii94.
27. Brose L. S., West R., Stapleton J. A. Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice. Mayo Clin Proc 2013; 88: 226–233.
28. Jarvis M., Wardle J. Social patterning of individual health behaviours: the case of cigarette smoking. In: Social Determinants of Health. Oxford: Oxford University Press; 2003. pp. 225–237. http://www.oxfordscholarship.com/view/10.1093/acprof:oso/9780198565895.001.0001/acprof-9780198565895-chapter-11
29. Hiscock R., Bauld L., Amos A., Platt S. Smoking and socioeconomic status in England: the rise of the never smoker and the disadvantaged smoker. J Public Health 2012; 34: 390–396.
30. Hill S., Amos A., Clifford D., Platt S. Impact of tobacco control interventions on socioeconomic inequalities in smoking: review of the evidence. Tob Control 2014; 23: e89–e97.
31. Hiscock R., Dobbie F., Bauld L. Smoking cessation and socioeconomic status: an update of existing evidence from a National Evaluation of English stop smoking services. Biomed Res Int 2015; 2015: 274056, 10. https://doi.org/10.1155/2015/274056. https://www.hindawi.com/journals/bmri/2015/274056/
32. West R., May S., West M., Croghan E., McEwen A. Performance of English stop smoking services in first 10 years: analysis of service monitoring data. BMJ 2013; 347: f4921.
33. Fidler J. A., Shahab L., West O., Jarvis M. J., McEwen A., Stapleton J. A., et al. ‘The Smoking Toolkit Study’: a national study of smoking and smoking cessation in England. BMC Public Health 2011; 11: 479.
34. Kotz D., Brown J., West R. Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study. Psychopharmacology (Berl) 2014; 231: 37–42.
35. Borland R., Partos T. R., Cummings K. M. Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res 2012; 14: 1483–1487.
36. West R. J., Hajek P., Belcher M. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med 1989; 19: 981–985.
37. Fidler J. A., Shahab L., West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components. Addiction 2011; 106: 631–638.
38. Kotz D., West R. Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control 2009; 18: 43–46.
39. Beard E., Brown J., West R., Kaner E., Meier P., Michie S. Associations between socio-economic factors and alcohol consumption: a population survey of adults in England. PLOS ONE 2019; 14: e0209442.
40. Dienes Z. Using Bayes to get the most out of non-significant results. Front Psychol 2014; 5: 781. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114196/
41. West R. Using Bayesian analysis for hypothesis testing in addiction science. Addiction 2015; 111: 3–4.
42. Hartmann-Boyce J., McRobbie H., Bullen C., Begh R., Stead L. F., Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2016CD010216.
43. Cahill K., Stead L. F., Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012; 4: CD006103.
44. Stead L. F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; 1: CD000146.
45. Stead L. F., Hartmann-Boyce J., Perera R., Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2013 [accessed 11 September 2018] CD002850; https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002850.pub3/abstract.
46. Barnes J., Dong C. Y., McRobbie H., Walker N., Mehta M., Stead L. F. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev 2010 [accessed 11 September 2018] CD001008; https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001008.pub2/abstract.
47. Boland V. C., Stockings E. A., Mattick R. P., McRobbie H., Brown J., Courtney R. J. The methodological quality and effectiveness of technology-based smoking cessation interventions for disadvantaged groups: a systematic review and meta-analysis. Nicotine Tob Res 2018; 20: 276–285.
48. Brown J., Michie S., Geraghty A. W., Yardley L., Gardner B., Shahab L., et al. Internet-based intervention for smoking cessation (StopAdvisor) in people with low and high socioeconomic status: a randomised controlled trial. Lancet Respir Med 2014; 2: 997–1006.
49. Kock L., Shahab L., West R., Brown J. E-cigarette use in England 2014–2017 as a function of socioeconomic profile. Addiction 2019; 114: 294–303. https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14446.
50. Borland R., Li L., Driezen P., Wilson N., Hammond D., Thompson M. E., et al. Cessation assistance reported by smokers in 15 countries participating in the International Tobacco Control (ITC) policy evaluation surveys. Addiction 2012; 107: 197–205.
51. Wong S. L., Shields M., Leatherdale S., Malaison E., Hammond D. Assessment of validity of self-reported smoking status. Health Rep 2012; 23: 47–53.
52. Taggar J. S., Coleman T., Lewis S., Szatkowski L. The impact of the quality and outcomes framework (QOF) on the recording of smoking targets in primary care medical records: cross-sectional analyses from the health improvement network (THIN) database. BMC Public Health 2012; 12: 329.
53. Lawrence D., Mitrou F., Zubrick S. R. Non-specific psychological distress, smoking status and smoking cessation: United States National Health Interview Survey 2005. BMC Public Health 2011; 11: 256.